13D/13G Filings - Celldex Therapeutics Inc. (CLDX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-14
2:59 pm
Sale
2025-06-3013GCelldex Therapeutics, Inc.
CLDX
Eventide Asset Management, LLC1,356,186
2.000%
-1,975,819decrease
(-59.30%)
Filing
History
2025-08-12
10:34 am
Sale
2025-06-3013GCelldex Therapeutics, Inc.
CLDX
Wellington Management Group LLP5,232,326
7.900%
-3,121,825decrease
(-37.37%)
Filing
History
2025-07-10
4:10 pm
Purchase
2025-07-0213GCelldex Therapeutics, Inc.
CLDX
Point72 Asset Management, L.P.4,464,400
6.700%
2,780,368increase
(+165.10%)
Filing
History
2025-05-15
11:48 am
Purchase
2025-03-3113GCelldex Therapeutics, Inc.
CLDX
Kynam Capital Management, LP6,500,000
9.790%
1,435,793increase
(+28.35%)
Filing
History
2025-05-12
10:44 am
Sale
2025-03-3113GCelldex Therapeutics, Inc.
CLDX
Wellington Management Group LLP8,354,151
12.600%
-889,448decrease
(-9.62%)
Filing
History
2025-04-17
09:35 am
Sale
2025-03-3113GCelldex Therapeutics, Inc.
CLDX
BlackRock Inc.
BLK
4,819,293
7.300%
-661,377decrease
(-12.07%)
Filing
History
2025-04-10
4:05 pm
Purchase
2025-04-0313GCelldex Therapeutics, Inc.
CLDX
Commodore Capital LP3,350,000
5.000%
3,350,000increase
(New Position)
Filing
History
2025-02-14
5:16 pm
Purchase
2024-12-3113GCelldex Therapeutics, Inc.
CLDX
Kynam Capital Management, LP5,064,207
7.630%
2,058,303increase
(+68.48%)
Filing
History
2025-02-14
09:44 am
Purchase
2024-12-3113GCelldex Therapeutics, Inc.
CLDX
T. Rowe Price Associates, Inc.3,557,136
5.400%
3,557,136increase
(New Position)
Filing
History
2025-02-12
09:28 am
Sale
2024-12-3113GCelldex Therapeutics, Inc.
CLDX
FMR LLC4,857,668
7.300%
-1,166,748decrease
(-19.37%)
Filing
History
2025-02-05
1:23 pm
Purchase
2024-12-3113GCelldex Therapeutics, Inc.
CLDX
BlackRock Inc.
BLK
5,480,670
8.300%
1,804,978increase
(+49.11%)
Filing
History
2024-11-14
7:47 pm
Sale
2024-09-3013GCelldex Therapeutics, Inc.
CLDX
Point72 Asset Management, L.P.1,684,032
2.500%
-1,072,090decrease
(-38.90%)
Filing
History
2024-11-14
12:18 pm
Sale
2024-09-3013GCelldex Therapeutics, Inc.
CLDX
Eventide Asset Management, LLC3,332,005
5.030%
-298,008decrease
(-8.21%)
Filing
History
2024-11-14
06:12 am
Sale
2024-09-3013GCelldex Therapeutics, Inc.
CLDX
RTW INVESTMENTS LP0
0.000%
-3,463,201decrease
(Position Closed)
Filing
History
2024-11-13
6:00 pm
Sale
2024-09-3013GCelldex Therapeutics, Inc.
CLDX
Polar Capital Holdings Plc2,711,163
4.090%
-424,708decrease
(-13.54%)
Filing
History
2024-11-12
09:55 am
Sale
2024-11-0813GCelldex Therapeutics, Inc.
CLDX
FMR LLC6,024,416
9.088%
-1,025,993decrease
(-14.55%)
Filing
History
2024-11-08
10:52 am
Purchase
2024-09-3013GCelldex Therapeutics, Inc.
CLDX
Wellington Management Group LLP9,243,599
13.940%
2,767,038increase
(+42.72%)
Filing
History
2024-02-14
4:17 pm
Sale
2023-12-3113GCelldex Therapeutics, Inc.
CLDX
Point72 Asset Management, L.P.2,756,122
5.000%
-866,014decrease
(-23.91%)
Filing
History
2024-02-14
12:52 pm
Purchase
2023-12-3113GCelldex Therapeutics, Inc.
CLDX
Kynam Capital Management, LP3,005,904
5.500%
3,005,904increase
(New Position)
Filing
History
2024-02-14
11:48 am
Purchase
2023-12-3113GCelldex Therapeutics, Inc.
CLDX
Eventide Asset Management, LLC3,630,013
6.640%
3,630,013increase
(New Position)
Filing
History
Goto 0, 1, 2, Next